These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
132 related items for PubMed ID: 2007534
21. Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervix. Niloff JM, Klug TL, Schaetzl E, Zurawski VR, Knapp RC, Bast RC. Am J Obstet Gynecol; 1984 Apr 15; 148(8):1057-8. PubMed ID: 6201072 [Abstract] [Full Text] [Related]
22. Changes in expression of differentiation markers between normal ovarian cells and derived tumors. Van Niekerk CC, Ramaekers FC, Hanselaar AG, Aldeweireldt J, Poels LG. Am J Pathol; 1993 Jan 15; 142(1):157-77. PubMed ID: 7678716 [Abstract] [Full Text] [Related]
23. Six new monoclonal antibodies to serous, mucinous, and poorly differentiated ovarian adenocarcinomas. Mettler L, Radzun HJ, Salmassi A, Köchling W, Parwaresch MR. Cancer; 1990 Apr 01; 65(7):1525-32. PubMed ID: 2178766 [Abstract] [Full Text] [Related]
24. Enhanced tumor binding using immunohistochemical analyses by second generation anti-tumor-associated glycoprotein 72 monoclonal antibodies versus monoclonal antibody B72.3 in human tissue. Molinolo A, Simpson JF, Thor A, Schlom J. Cancer Res; 1990 Feb 15; 50(4):1291-8. PubMed ID: 2297774 [Abstract] [Full Text] [Related]
25. Serum levels and biochemical characteristics of human ovarian carcinoma-associated antigen defined by murine monoclonal antibody, CF511. Ohkawa K, Tsukada Y, Murae M, Kimura E, Takada K, Abe T, Terashima Y, Mitani K. Br J Cancer; 1989 Dec 15; 60(6):953-60. PubMed ID: 2605105 [Abstract] [Full Text] [Related]
26. Adjunct to the diagnostic distinction between adenocarcinomas of the ovary and the colon utilizing a monoclonal antibody (COL-4) with restricted carcinoembryonic antigen reactivity. Thor A, Muraro R, Gorstein F, Ohuchi N, Viglione M, Szpak CA, Johnston WW, Schlom J. Cancer Res; 1987 Jan 15; 47(2):505-12. PubMed ID: 2431771 [Abstract] [Full Text] [Related]
27. [Evaluation of epithelial ovarian neoplasm immunologic reactivity using monoclonal antibodies]. Bar J, Sobańska E. Ginekol Pol; 1994 Sep 15; 65(9):502-7. PubMed ID: 7721163 [Abstract] [Full Text] [Related]
28. Reactivity of monoclonal antibodies directed against lung cancer antigens with human lung, breast and colon cancer cell lines. Schumacher U, Mukthar D, Schenker T. Dis Markers; 1993 Dec 15; 11(5-6):225-37. PubMed ID: 8082312 [Abstract] [Full Text] [Related]
29. Distinguishing breast carcinoma from Müllerian serous carcinoma with mammaglobin and mesothelin. Kanner WA, Galgano MT, Stoler MH, Mills SE, Atkins KA. Int J Gynecol Pathol; 2008 Oct 15; 27(4):491-5. PubMed ID: 18753974 [Abstract] [Full Text] [Related]
30. Monoclonal antibodies against native ovarian tumor cells: specificity and characterization of the antigen. A preliminary report. Wasserman L, Neri A, Kaplan B, Manor Y, Galli M, Hardy B. J Cancer Res Clin Oncol; 1995 Oct 15; 121(7):387-92. PubMed ID: 7543483 [Abstract] [Full Text] [Related]
31. Expression of MHC products and leucocyte differentiation antigens in gynaecological neoplasms: an immunohistological analysis of the tumour cells and infiltrating leucocytes. Ferguson A, Moore M, Fox H. Br J Cancer; 1985 Oct 15; 52(4):551-63. PubMed ID: 2415145 [Abstract] [Full Text] [Related]
32. [Tumor antigens CA 125 and CA l9-9 in the serum of patients with gynecologic trophoblastic tumors and colorectal carcinoma]. Göcze P, Szabó D, Than G, Csaba I, Krommer K. Orv Hetil; 1986 Aug 31; 127(35):2123-6. PubMed ID: 3024089 [No Abstract] [Full Text] [Related]
33. Immunoperoxidase localization of a high-molecular-weight mucin recognized by monoclonal antibody 1D3. Gangopadhyay A, Bhattacharya M, Chatterjee SK, Barlow JJ, Tsukada Y. Cancer Res; 1985 Apr 31; 45(4):1744-52. PubMed ID: 3884144 [Abstract] [Full Text] [Related]
34. Complementary reactivities of anti-carcinoembryonic antigen and antitumor-associated glycoprotein 72 monoclonal antibodies in lung carcinomas. Battista P, Muraro R, Mammarella S, Curia MC, Colasante A, Rosini S, Lesti G, Sacco R, French D, Frati L. Cancer Res; 1990 Nov 01; 50(21):6987-94. PubMed ID: 1698547 [Abstract] [Full Text] [Related]
35. In vivo targeting of OV-TL 3 immunoliposomes to ascitic ovarian carcinoma cells (OVCAR-3) in athymic nude mice. Nässander UK, Steerenberg PA, Poppe H, Storm G, Poels LG, De Jong WH, Crommelin DJ. Cancer Res; 1992 Feb 01; 52(3):646-53. PubMed ID: 1732053 [Abstract] [Full Text] [Related]
36. Tumor markers for ovarian cancer. A comparative immunohistochemical and immunocytochemical study of two commercial monoclonal antibodies (OV632 and OC125). Koelma IA, Nap M, van Steenis GJ, Fleuren GJ. Am J Clin Pathol; 1988 Oct 01; 90(4):391-6. PubMed ID: 2459953 [Abstract] [Full Text] [Related]
37. Generation and characterization of B72.3 second generation monoclonal antibodies reactive with the tumor-associated glycoprotein 72 antigen. Muraro R, Kuroki M, Wunderlich D, Poole DJ, Colcher D, Thor A, Greiner JW, Simpson JF, Molinolo A, Noguchi P. Cancer Res; 1988 Aug 15; 48(16):4588-96. PubMed ID: 3396010 [Abstract] [Full Text] [Related]
38. Immunopathologic analysis of a panel of mouse monoclonal antibodies reacting with human ovarian carcinomas and other human tumors. Cordon-Cardo C, Mattes MJ, Melamed MR, Lewis JL, Old LJ, Lloyd KO. Int J Gynecol Pathol; 1985 Aug 15; 4(2):121-30. PubMed ID: 3894261 [Abstract] [Full Text] [Related]
39. Comparison of a rabbit heteroantiserum and a murine monoclonal antibody raised against a human epithelial ovarian carcinoma cell line. Berkowitz R, Kabawat S, Lazarus H, Colvin R, Knapp R, Bast RC. Am J Obstet Gynecol; 1983 Jul 15; 146(6):607-12. PubMed ID: 6346879 [Abstract] [Full Text] [Related]
40. Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3. Thor A, Ohuchi N, Szpak CA, Johnston WW, Schlom J. Cancer Res; 1986 Jun 15; 46(6):3118-24. PubMed ID: 3516392 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]